Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-29T20:44:18.891Z Has data issue: false hasContentIssue false

Recovery from sensorineural deafness in Wegener's granulomatosis

Published online by Cambridge University Press:  29 June 2007

M. R. Clements*
Affiliation:
Lecturer, University Department of Medicine, Royal Infirmary, Manchester
C. D. Mistry
Affiliation:
Senior Registrar, Renal Unit, Royal Infirmary, Manchester
A. O. Keith
Affiliation:
Senior Registrar, University Department of Otolaryngology, Royal Infirmary, Manchester
R. T. Ramsden
Affiliation:
Consultant Otolaryngologist, University Department of Otolaryngology, Royal Infirmary, Manchester.
*
Dr M. R. Clements, M.D., M.R.C.P., University Department of Medicine, Royal Infirmary, Manchester M13 9WL

Abstract

Wegener's granulomatosis may present with deafness or other aural symptoms. This report describes two patients with histological evidence of Wegener's granulomatosis who developed reversible sensorineural hearing loss during the course of their illness. The first patient showed complete recovery of a sensorineural hearing loss averaging 50 dB after ten months treatment with cyclophosphamide and high-dose prednisolone. The second patient, who was on maintenance haemodialysis, achieved a 40 dB improvement in sensorineural hearing loss within two weeks of adding cyclophosphamide to pre-existing corticosteroid therapy. These findings suggest that the prognosis of sensorineural hearing loss in Wegener's granulomatosis can be improved with suppression of the vasculitic process by early treatment with combined cytotoxic-immunosuppressive therapy

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Blatt, I. M. and Lawrence, M. (1961) Otologic manifestations of fatal granulomatosis of respiratory tract. Archives of Otolaryngology, 73: 639643.CrossRefGoogle Scholar
Blatt, I. M., Seltzer, H. S., Rubin, P., Furstenberg, A. C, Maxwell, J. H. and Schull, W. J. (1959) Fatal granulomatosis of the respiratory tract (lethal midline granuloma-Wegener's granulomatosis). Archives of Otolaryngology, 70: 707757.CrossRefGoogle ScholarPubMed
Case records of the Massachusetts General Hospital: Weekly clinicopathological exercises: Case 87. (1961) Wegener's granulomatosis. New England Journal of Medicine, 265: 11561164.Google Scholar
Cody, D. T. R. and Sones, D. A. (1971) Relapsing polychondritis: audiovestibular manifestations. Laryngoscope, 81: 12081222.CrossRefGoogle ScholarPubMed
Drachman, D. A. (1963) Neurological complications of Wegener's granulomatosis. Archives of Neurology, 8: 145155.CrossRefGoogle Scholar
Editorial. (1968) Antimetabolites and immunoinflammatory diseases. New England Journal of Medicine, 278(5): 277278.CrossRefGoogle Scholar
Fauci, A. S., Haynes, B. F., Katz, P. and Wolff, S. M. (1983) Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Annals of Internal Medicine, 98: 7685.CrossRefGoogle Scholar
Fauci, A. S., Horn, R. G., Dale, D. C. and Wolff, S. M. (1974) Wegener's granulomatosis (NIH conference). Annals of Internal Medicine, 81: 513525.Google Scholar
Francis, D. A. and Boddie, H. G. (1982) Acute hearing loss in giant cell arteritis. Postgraduate Medical Journal, 58: 357358.CrossRefGoogle ScholarPubMed
Friedmann, I. and Bauer, F. (1973) Wegener's granulomatosis causing deafness. Journal of Laryngology and Otology, 87(1): 449464.CrossRefGoogle ScholarPubMed
Froud, P. J. and Henderson, A. H. (1971) The treatment of Wegener's granulomatosis with immunosuppressive-cytotoxic drugs. Journal of Laryngology and Otology, 85: 703710.CrossRefGoogle ScholarPubMed
Godman, G. C. and Churg, J. (1954) Wegener's granulomatosis. Archives of Pathology, 58: 533553.Google ScholarPubMed
Grahne, B. and Zechner, G. (1966) Wegener's granulomatosis. Acta Otolaryngologica, 62: 362372.CrossRefGoogle ScholarPubMed
Hollander, D. and Manning, R. T. (1967) The use of alkylating agents in the treatment of Wegener's granulomatosis. Annals of Internal Medicine, 67(2): 393398.CrossRefGoogle ScholarPubMed
Klinger, H. (1931) Grenzformen der Periarteritis nodosa. Frankfurter Zeitschrift Pathologie, 42: 455–80.Google Scholar
McCabe, B. F. (1987). In: Oto-Immunology (Velman, J. E. and McCabe, B. F., eds.), pp. 143148, Kugler Publications, Amstelveen.Google Scholar
Moore, P. M., Beard, E. E., Thoburn, T. W. and Williams, H. L. (1951) Idiopathic (lethal) granuloma of the midline facial tissues treated with cortisone: report of a case. Laryngoscope, 61: 320331.CrossRefGoogle ScholarPubMed
Morrison, A. W. and Booth, J. B. (1970) Sudden deafness: an otological emergency. British Journal of Hospital Medicine, 4: 287298.Google Scholar
Peitersen, E. and Carlsen, B. H. (1965) Hearing impairment as the initial sign of polyarteritis nodosa. Acta Otolaryngologica, 61: 189195.CrossRefGoogle Scholar
Per-Lee, J. H. and Parsons, R. C. (1969) Vasculitis presenting as otitis media. Southern Medical Journal, 62: 161165.CrossRefGoogle ScholarPubMed
Rabuzzi, D. D. (1970) Relapsing polychondritis. Archives of Otolaryngology, 91: 188194.CrossRefGoogle ScholarPubMed
Veldman, J. E. and McCabe, B. F. (1987). In: Oto-Immunology (Veldman, J. E. and McCabe, B. F., eds.), Introduction, Kugler Publications, Amstelveen.Google ScholarPubMed
Walton, E. W. (1958) Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). British Medical Journal, 2: 265270.CrossRefGoogle ScholarPubMed
Wegener, F. (1936) Uber generalisierte septische Gefasserkrankungen. Verhandlungen der Deutschen Gesellschaft fur Pathologie, 29: 202209.Google Scholar
Wegener, F. (1939) Uber eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems und der Nieren. Beitraege zur Pathologischen Anatomie and zur allgemeinen Pathologie, 102: 3668.Google Scholar